Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review

Abstract For decades, topical corticosteroids have been the mainstay of treatment for mild-to-moderate inflammatory skin diseases, even though only short-term use is approved for these agents and systemic inflammation is not addressed. Increased understanding of the immunopathogenesis of these condi...

Full description

Bibliographic Details
Main Authors: Andrew Blauvelt, Richard G. Langley, Kenneth B. Gordon, Jonathan I. Silverberg, Kilian Eyerich, Morten O. A. Sommer, Jakob Felding, Richard B. Warren
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Dermatology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s13555-023-01054-3